Divalproex Sodium
- Product NDC
- 70518-2513
- 11-digit product format
- 705182513
- Labeler code
- 70518
- Product ID
- 70518-2513_e08ad15e-1d61-21fb-e053-2a95a90aaf9d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Divalproex Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078597
- Marketing category
- ANDA
- Marketing start
- 2019-12-30
- Marketing end
- 0000-00-00
- Substance
- DIVALPROEX SODIUM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2513-0 | 70518251300 | 100 POUCH in 1 BOX (70518-2513-0) > 1 TABLET, DELAYED RELEASE in 1 POUCH (70518-2513-1) | 100 pouch | 2019-12-30 | 0000-00-00 | No | No | Current |
| 70518-2513-2 | 70518251302 | 60 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70518-2513-2) | | 2022-03-21 | 0000-00-00 | No | No | Current |